{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:19:18Z","timestamp":1790176758927,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.vaccine.2017.06.018","type":"journal-article","created":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T07:30:42Z","timestamp":1498030242000},"page":"3930-3937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Optimizing adjuvants for intradermal delivery of MenC glycoconjugate vaccine"],"prefix":"10.1016","volume":"35","author":[{"given":"Agnese","family":"Donadei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Balocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria R.","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Panza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Adamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Berti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek T.","family":"O'Hagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Gallorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara C.","family":"Baudner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.06.018_b0005","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/irv.12000","article-title":"A meta-analysis of intradermal versus intramuscular influenza vaccines: immunogenicity and adverse events","volume":"7","author":"Marra","year":"2013","journal-title":"Influenza Other Respi Viruses"},{"key":"10.1016\/j.vaccine.2017.06.018_b0010","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1016\/j.vaccine.2013.03.008","article-title":"Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18\u201364 years of age","volume":"31","author":"Gorse","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.06.018_b0015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.biomaterials.2015.04.007","article-title":"Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch","volume":"57","author":"Hirobe","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2017.06.018_b0020","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.1016\/j.vaccine.2015.10.081","article-title":"Functional anti-polysaccharide IgG titers induced by unadjuvanted pneumococcal-conjugate vaccine when delivered by microprojection-based skin patch","volume":"33","author":"Pearsona","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.06.018_b0025","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.12.30176","article-title":"Increased incidence of invasive meningococcal disease of serogroup C\/clonal complex 11, Tuscany, Italy, 2015 to 2016","volume":"21","author":"Stefanelli","year":"2016","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.vaccine.2017.06.018_b0030","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1016\/j.vaccine.2007.01.043","article-title":"Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study","volume":"25","author":"McKenzie","year":"2007","journal-title":"Vaccine"},{"issue":"35","key":"10.1016\/j.vaccine.2017.06.018_b0035","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1016\/j.vaccine.2008.05.083","article-title":"Neonatal immune response and serum bactericidal activity induced by a meningococcal conjugate vaccine is enhanced by LT-K63 and CpG2006","volume":"26","author":"Brynjolfsson","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.06.018_b0040","first-page":"727","article-title":"Recent advances in the discovery and delivery of vaccine adjuvants","volume":"2","author":"O\u2019Hagan","year":"2003","journal-title":"Nat Rev"},{"key":"10.1016\/j.vaccine.2017.06.018_b0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1084\/jem.20030324","article-title":"Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein","volume":"198","author":"Fujii","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2017.06.018_b0050","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-1-4615-1823-5_10","article-title":"MF59 design and evaluation of a safe and potent adjuvant for human vaccines","volume":"6","author":"Ott","year":"1995","journal-title":"Pharm Biotechnol"},{"key":"10.1016\/j.vaccine.2017.06.018_b0055","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.4049\/jimmunol.180.8.5402","article-title":"The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells","volume":"180","author":"Monaci","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.06.018_b0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/erv.12.140","article-title":"The history of MF59\u00ae adjuvant: a Phoenix that arose from the ashes","volume":"12","author":"O'Hagan","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.06.018_b0065","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fimmu.2013.00157","article-title":"Skin-resident antigen-presenting cells: instruction manual for vaccine development","volume":"4","author":"Fehres","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2017.06.018_b0070","doi-asserted-by":"crossref","first-page":"e41501","DOI":"10.1371\/journal.pone.0041501","article-title":"Effect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccine","volume":"7","author":"Weldon","year":"2012","journal-title":"PLoS One."},{"key":"10.1016\/j.vaccine.2017.06.018_b0075","series-title":"New generation vaccines","first-page":"284","article-title":"Recent developments in non living antigen delivery systems","author":"O'Hagan","year":"2010"},{"key":"10.1016\/j.vaccine.2017.06.018_b0080","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/jat.1223","article-title":"Pollinex\u00ae Quattro Ragweed: safety evaluation of a new allergy vaccine adjuvanted with monophosphoryl lipid A (MPL\u00ae) for the treatment of ragweed pollen allergy","volume":"27","author":"Baldrick","year":"2007","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.vaccine.2017.06.018_b0085","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0264-410X(00)00499-0","article-title":"The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine","volume":"19","author":"Podda","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.06.018_b0090","doi-asserted-by":"crossref","first-page":"776","DOI":"10.4049\/jimmunol.181.1.776","article-title":"Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant","volume":"181","author":"Adams","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.06.018_b0095","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/nchembio.1650","article-title":"A semisynthetic carbohydrate-lipid vaccine that protects against S. pneumoniae in mice","volume":"10","author":"Cavallari","year":"2014","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.vaccine.2017.06.018_b0100","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.addr.2012.04.005","article-title":"Microneedles for drug and vaccine delivery","volume":"64","author":"Kim","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2017.06.018_b0105","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1473-3099(04)01222-8","article-title":"Revolutionary vaccine technology breaks the cold chain","volume":"4","author":"Das","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.06.018_b0110","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.vaccine.2008.01.022","article-title":"Physicochemical characterisation of glycoconjugate vaccines for prevention of meningococcal diseases","volume":"26","author":"Bardotti","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.06.018_b0115","doi-asserted-by":"crossref","first-page":"9192","DOI":"10.1021\/jo8019994","article-title":"Fallarini S, Lombardi G. Synthesis of \u03b1-galactosyl ceramide (KRN7000) and analogues thereof via a common precursor and their preliminary biological assessment","volume":"73","author":"Michieletti","year":"2008","journal-title":"J Org Chem"},{"key":"10.1016\/j.vaccine.2017.06.018_b0120","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/jps.24337","article-title":"The development of self-emulsifying oil-in-water emulsion adjuvant and an evaluation of the impact of droplet size on performance","volume":"104","author":"Shah","year":"2015","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2017.06.018_b0125","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4049\/jimmunol.177.1.501","article-title":"The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance","volume":"177","author":"Madico","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.06.018_b0130","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1016\/j.vaccine.2013.12.043","article-title":"Sublingual immunization with a subunit influenza vaccine elicits comparable systemic immune response as intramuscular immunization, but also induces local IgA and TH17 responses","volume":"32","author":"Gallorini","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.06.018_b0135","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1034\/j.1398-9995.2000.00501.x","article-title":"Aluminium-induced granulomas after inaccurate intradermal hyposensitization injections of aluminium-adsorbed depot preparations","volume":"55","author":"Vogelbruch","year":"2000","journal-title":"Allergy"},{"key":"10.1016\/j.vaccine.2017.06.018_b0140","doi-asserted-by":"crossref","first-page":"263ra160","DOI":"10.1126\/scitranslmed.3009980","article-title":"Rational design of small molecules as vaccine adjuvants","volume":"6","author":"Wu","year":"2014","journal-title":"Sci Trans Med"},{"key":"10.1016\/j.vaccine.2017.06.018_b0145","doi-asserted-by":"crossref","first-page":"9192","DOI":"10.1021\/jo8019994","article-title":"Synthesis of \u03b1-galactosyl ceramide (KRN7000) and analogues thereof via a common precursor and their preliminary biological assessment","volume":"73","author":"Michieletti","year":"2008","journal-title":"J Org Chem"},{"key":"10.1016\/j.vaccine.2017.06.018_b0150","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1021\/acs.molpharmaceut.5b00072","article-title":"Rational design of adjuvant for skin delivery: conjugation of synthetic beta-glucan dectin-1 agonist to protein antigen","volume":"12","author":"Donadei","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1016\/j.vaccine.2017.06.018_b0155","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5582\/ddt.2015.01025","article-title":"Polysaccharides: candidates of promising vaccine adjuvants","volume":"9","author":"Li","year":"2015","journal-title":"Drug Discov Ther"},{"key":"10.1016\/j.vaccine.2017.06.018_b0160","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00284-009-9505-9","article-title":"Purified capsular polysaccharide of Neisseria meningitidis serogroup A as immune potentiator for antibody production","volume":"60","author":"Menendez","year":"2010","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.vaccine.2017.06.018_b0165","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.vaccine.2014.11.026","article-title":"Carrier priming with CRM197or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: biophysical and immunochemical interpretation","volume":"33","author":"Pecetta","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.06.018_b0170","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1128\/IAI.67.3.1100-1106.1999","article-title":"Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants","volume":"67","author":"Glenn","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.06.018_b0175","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4161\/hv.7.0.14560","article-title":"Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine","volume":"7","author":"Durando","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2017.06.018_b0180","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.4049\/jimmunol.171.10.5140","article-title":"NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells","volume":"171","author":"Hermans","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.06.018_b0185","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1002\/eji.201344094","article-title":"Topical rather than intradermal application of the TLR7 ligand imiquimod leads to human dermal dendritic cell maturation and CD8+ T-cell cross-priming","volume":"44","author":"Fehres","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2017.06.018_b0190","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1038\/jid.2015.226","article-title":"In situ delivery of tumor antigen\u2013 and adjuvant-loaded liposomes boosts antigen-specific t-cell responses by human dermal dendritic cells","volume":"135","author":"Boks","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.vaccine.2017.06.018_b0195","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1016\/j.vaccine.2008.05.083","article-title":"Jonsdottir I. Neonatal immune response and serum bactericidal activity induced by a meningococcal conjugate vaccine is enhanced by LT-K63 and CpG2006","volume":"26","author":"Brynjolfsson","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.06.018_b0200","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4161\/hv.19229","article-title":"MF59 oil-in-water emulsion in combination with a synthetic TLR4 agonist (E6020) is a potent adjuvant for a combination Meningococcus vaccine","volume":"8","author":"Singh","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2017.06.018_b0205","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1128\/IAI.05019-11","article-title":"The Neisseria meningitidis macrophage infectivity potentiator protein induces cross-strain serum bactericidal activity and is a potential serogroup B vaccine candidate","volume":"79","author":"Hung","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.06.018_b0210","doi-asserted-by":"crossref","first-page":"19008","DOI":"10.1074\/jbc.M311618200","article-title":"Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors","volume":"279","author":"Nishiya","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2017.06.018_b0215","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1182\/blood-2010-12-328138","article-title":"Small molecule Toll-like receptor 7 agonists localize to the MHC class II loading compartment of human plasmacytoid dendritic cells","volume":"117","author":"Russo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2017.06.018_b0220","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.0300-9475.2004.01362.x","article-title":"The four mouse IgG isotypes differ extensively in bactericidal and opsonophagocytic activity when reacting with the P1.16 epitope on the outer membrane PorA protein of Neisseria meningitidis","volume":"59","author":"Michaelsen","year":"2004","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2017.06.018_b0225","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/nm0901-1052","article-title":"The natural killer T-cell ligand \u03b1-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice","volume":"7","author":"Hong","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2017.06.018_b0230","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.vaccine.2014.01.076","article-title":"Microneedle patches: usability and acceptability for self-vaccination against influenza","volume":"32","author":"Norman","year":"2014","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2017.06.018_b0235","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/CVI.00529-09","article-title":"Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity","volume":"17","author":"Campbell","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2017.06.018_b0240","doi-asserted-by":"crossref","first-page":"6456","DOI":"10.1016\/j.vaccine.2012.08.004","article-title":"Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2\u201310 years: a Phase II\/III double-blind randomized controlled trial","volume":"30","author":"Hirve","year":"2012","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17307958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17307958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T21:33:50Z","timestamp":1750368830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17307958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":48,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0264410X17307958"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.06.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing adjuvants for intradermal delivery of MenC glycoconjugate vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}